Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT-2: Initial Invasive vs Conservative Strategy for Vulnerable Coronary Plaques
NCT07569692Not yet recruiting
- Sponsor
- Duk-Woo Park
- Start
- Dec 2026
- Primary completion
- Jul 2031
- Countries
- 1
01
Overview
Randomised trial in coronary artery disease (CAD) (2 arms), sponsored by Duk-Woo Park. Primary endpoint: Composite of death from cardiac causes, target-vessel myocardial infarction, unplanned urgent revascularization, or hospitalization for unstable or progressive angina at 3 years. Planned start Dec 2026; status: not yet recruiting.
02
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT07569692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07569692.